Effect of Ferritin, INR, and D-dimer Immunological Parameters Levels As Predictors of COVID-19 Mortality: A Strong Prediction with the Decision Trees
Overview
Authors
Affiliations
Background And Objective: A hyperinflammatory environment is thought to be the distinctive characteristic of COVID-19 infection and an important mediator of morbidity. This study aimed to determine the effect of other immunological parameter levels, especially ferritin, as a predictor of COVID-19 mortality via decision-trees analysis.
Material And Method: This is a retrospective study evaluating a total of 2568 patients who died (n = 232) and recovered (n = 2336) from COVID-19 in August and December 2021. Immunological laboratory data were compared between two groups that died and recovered from patients with COVID-19. In addition, decision trees from machine learning models were used to evaluate the performance of immunological parameters in the mortality of the COVID-19 disease.
Results: Non-surviving from COVID-19 had 1.75 times higher ferritin, 10.7 times higher CRP, 2.4 times higher D-dimer, 1.14 times higher international-normalized-ratio (INR), 1.1 times higher Fibrinogen, 22.9 times higher procalcitonin, 3.35 times higher troponin, 2.77 mm/h times higher erythrocyte-sedimentation-rate (ESR), 1.13sec times longer prothrombin time (PT) when compared surviving patients. In addition, our interpretable decision tree, which was constructed with only the cut-off values of ferritin, INR, and D-dimer, correctly predicted 99.7% of surviving patients and 92.7% of non-surviving patients.
Conclusions: This study perfectly predicted the mortality of COVID-19 with our interpretable decision tree constructed with INR and D-dimer, especially ferritin. For this reason, we think that it may be important to include ferritin, INR, and D-dimer parameters and their cut-off values in the scoring systems to be planned for COVID-19 mortality.
Safdari A, Keshav C, Mody D, Verma K, Kaushal U, Burra V PLoS One. 2025; 20(2):e0316467.
PMID: 39903736 PMC: 11793750. DOI: 10.1371/journal.pone.0316467.
Abdollahi A, Nateghi S, Panahi Z, Inanloo S, Salarvand S, Pourfaraji S BMC Infect Dis. 2024; 24(1):1373.
PMID: 39623325 PMC: 11610108. DOI: 10.1186/s12879-024-10229-y.
Akbari M, Dehghani Y, Shirzadi M, Pourajam S, Hosseinzadeh M, Sajadi M Front Public Health. 2024; 12:1411314.
PMID: 39314786 PMC: 11416957. DOI: 10.3389/fpubh.2024.1411314.
Karimi Z, Malak J, Aghakhani A, Najafi M, Ariannejad H, Zeraati H Health Sci Rep. 2024; 7(9):e70041.
PMID: 39229475 PMC: 11369020. DOI: 10.1002/hsr2.70041.
Bedair N, Abdelaziz A, Abdelrazik F, El-Kassas M, AbouHadeed M Arch Dermatol Res. 2024; 316(6):336.
PMID: 38844670 PMC: 11156737. DOI: 10.1007/s00403-024-03004-1.